Reuters logo
Karo Pharma says clarifies bid financing details due to trading halt
August 24, 2017 / 1:44 PM / 3 months ago

Karo Pharma says clarifies bid financing details due to trading halt

STOCKHOLM, Aug 24 (Reuters) - Karo Pharma:

* Says regarding financing of bid for Norway’s Weifa ASA , Co wants to make the following clarification:

* Says Swedbank will supply loan and bridge financing until the firm has carried out a rights issue for repayment of the bridge financing, which was mentioned in a previous press release on Thursday

* Says during webcast at 0900 GMT on Thursday Karo Pharma mentioned as an example a relation between loan and rights issue of 50/50 pct. As previously stated in the press release, the relation has not yet been decided on

* Says decision and conditions for the rights issue will therefore be subject to further consideration by the Board

* Trading in Karo Pharma’s shares was halted earlier on Thursday, to be resumed again at 1400 GMT

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below